This technology employs CRISPR-mediated inactivation of the MLH1 gene within CT26 and MC-38 murine colorectal tumor cell lines to simulate DNA mismatch repair deficiency, resulting in microsatellite instability. It enables the creation of isogenic models that allow researchers to directly compare tumor behavior in both immuno-compromised and immuno-competent environments. The modified cells exhibit distinct growth patterns, apoptotic activity, and cytokine expression, as well as increased CD8+ T cell infiltration, providing a comprehensive platform to study how DNA repair defects can influence tumor dynamics and immune interactions.